Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
56 Cards in this Set
- Front
- Back
Trophic triggers for hypertrophy
|
Mechanical triggers: stretch
and Trophic triggers: polypeptide growth factors and vasoactive agents |
|
Common causes of pathologic atrophy
|
Decreased work load, loss of innervation, diminished blood supply, inadequate nutrition, loss of endocrine stimulation, aging, pressure
|
|
Mechanisms of atrophy
|
Protein degradation (lysosomes, ubiquitin, proteasomes), glucocorticoids/thyroid hormone/cytokines (TNF) stimulate proteosome mediated degredtion, increases in autophagic vacuoles
|
|
Hallmarks of reversible cell injury
|
Reduced oxidative phosphorylation, ATP depletion, cellular swelling
-- general swelling of the cell/organelles, blebbing, ribosome detachment, chromatin clumping |
|
Causes of cell injury
|
Hypoxia (ischemia, inadequate oxygenation, reduced oxygen carrying capacity), physical agents, chemical agents, infectious agents, immunologic reactions, genetic derangements, nutritional imbalances
|
|
Transition to irreversible injury: characteristics
|
Increased swelling, disruption of lysosomes, large amorphous densities in swollen mitochondria, disruption of cellular membranes, profound nuclear changes (pyknosis, karyorrhexis, karyolysis), laminated structures become more pronounced
|
|
Necrosis v. apoptosis:
cell size |
N: enlarged
A: reduced |
|
Necrosis v. apoptosis:
Nucleus |
N: Pyknosis, karyorrhexis, karyolysis
A: Fragmentation into nucleosome size fragments |
|
Necrosis v. apoptosis:
Plasma membrane |
N: Disrupted
A: Intact; altered structure, esp. lipid orientation |
|
Necrosis v. apoptosis:
Cellular contents |
N: Enzymatic digestion
A: Intact |
|
Cell injury results from abnormalities in one or more of which five essential cellular components
|
Aerobic cell respiration, maintenance of membrane integrity, protein synthesis, intracellular cytoskeleton, integrity of the genetic apparatus
|
|
Intracellular mechanisms of cell injury
|
ATP depletion, mitochondrial damage, loss of calcium homeostasis, accumulation of oxygen derived free radicals, defects in membrane permeability
|
|
ATP depletion effects
|
Sodium pump dysregulation (swelling, ER dilation, loss of microvilli), alteration of cellular energy metabolism (reduced pH; decreased enzyme activity, clumping of chromatin), failure of Ca pump, detachment of ribosomes (reduction in protein synthesis; lipid deposition), unfolded protein response
|
|
Causes of mitochondrial damage
|
Increases in cytosolic Ca, oxidative stress, breakdown of phospholipids through the phospholipase A2 and sphingomyelin pathways, lipid breakdown products
|
|
Free radical initiation
|
Radiant energy, enzymatic metabolism of exogenous chemicals, normal redox reactions, transition metals, nitric oxide
|
|
Relevant free radical effects
|
Lipid peroxidation of membranes, oxidative modifications to proteins, lesions in DNA
|
|
Systems that inactivate free radicals
|
Antioxidants, transition metal binding proteins, free radical scavenging enzymes: catalase, superoxide dismutase, glutathione peroxidase (hydrogen peroxide and superoxide anion)
|
|
Consistent irreversibility characteristics
|
Inability to reverse mitochondrial dysfunction, and profound disturbances in membrane function
|
|
Biochemical mechanisms that contribute to membrane damage
|
Mitochondrial dysfunction, loss of membrane phospholipids, cytoskeletal abnormalities, reactive oxygen species, lipid breakdown products
|
|
Morphologic features of reversible injury
|
Cell swelling and fatty change
-- plasma membrane alterations, mitochondrial changes, dilation of ER, nuclear alterations |
|
General necrotic morphology
|
Increased eosinophilia, nuclear changes (p, k, k), glassy appearance (glycogen loss), vacuolated, may attract calcium salts
|
|
Morphologic appearance of necrosis is the result of?
|
Denaturation of intracellular proteins and enzymatic digestion of the cell
|
|
Coagulative necrosis
|
Protein denaturation, preservation of cell and tissue framework, characteristic of hypoxic death, either heterolysis or autolysis
|
|
Liquefactive necrosis
|
Autolysis/heterolysis predominates over protein denaturation, abcesses/brain tissue, focal bacterial/occasionally fungal
|
|
Caseous necrosis
|
TB lesions, eosinophilic amorphous material with cell debris, fragmented coagulated cells, distinctive inflammatory border
|
|
Fat necrosis
|
Lipase activation releases fatty acids from triglycerides, then complex with calcium
|
|
Wet gangrene
|
when bacterial infection is superimposed on coagulative necrosis
|
|
Ischemia: reversible injury
|
Na/K pump, Ca release, swelling, ER dilation, increase osmotic load, detachment of ribosomes, decreased protein synthesis, altered cellular metabolism
|
|
Ischemia: irreversible injury
|
MPT change, release of cytochrome c, activated membrane phospholipases, decreased ATP causes decreased phospholipid synthesis, activated intracellular proteases, accumulation of free fatty acids and lysophospholipids
|
|
Mechanisms underlying reperfusion injury
|
Increased generation of free radicals, MPT promotion, increased cytokine/adhesion molecule expression causes inflammation that is increased when blood flow resumes, deposition of IgM binds to complement proteins when flow resumes and cause injury and inflammation
|
|
Apoptosis in physiologic situations
|
embryogenesis, hormone dependent involution, cell deletion in proliferating cell populations, dead of host cells that have served their useful purpose, eliminations of self-reactive lymphocytes, cell death induced by cytotoxic T cells
|
|
Apoptosis in pathologic conditions
|
Death produced by a variety of injurious stimuli, injury in certain viral diseases, pathologic atrophy in parenchymal organs after duct obstruction, cell death in tumors
|
|
Biochemical features of apoptosis
|
Protein cleavage by caspases (may also activate DNAases), intranucleosomal cleavage of DNA (200 bp), plasma membrane alterations
|
|
Cytotoxic T lymphocytes and apoptosis
|
Secretes perforin, then secretes granzyme B, which enters the cell and cleaves proteins, activating caspases. also express FasL on their surface
|
|
Autophagic vacuole
|
Where intracellular organelles and portions of cytosol are sequestered, formed from ribosome-free regions of the ER; eventually fuse to form autophagolysosome
|
|
Lipofuscin pigment
|
Undigested material derived from intracellular lipid peroxidation. Composed of complex lipids, phospholipids, and protein
|
|
Mitochondrial alterations
|
Increase/decrease in number during hypertrophy/atrophy, megamitochondria, mitochondrial myopathies, oncocytomas
|
|
Cytoskeleton
|
Microtubules, thin actin filaments, thick myosin filaments, intermediate filaments
|
|
Thin filaments
|
Leukocyte movement/phagocytosis
|
|
Microtubules
|
Sperm, cilia, leukocyte migration, phagocytosis
|
|
Intermediate filaments
|
Organizes cytoplasm
|
|
Abnormalities that result in accumulations
|
Normal, endogenous substance produced at normal/increased rate and rate of metabolism is inadequate; normal/abnormal endogenous compound accumulates bc of genetic/acquired defects in metabolism, packaging, transport, secretion; abnormal exogenous substance accumulates; can be reversible
|
|
Steatosis
|
Caused by alcohol abuse, protein malnutrition, diabetes, obesity, hepatotoxins, anoxia
|
|
Steatosis: causes
|
Excessive entry, excessive synthesis, decreased oxidation, increased esterification to triglycerides (due to alpha-glycerophosphate; alcohol), decreased apoprotein synthesis (carbon tetrachloride poisoning, starvation), impaired lipoprotein secretion (alcohol)
|
|
Cholesterol related pathologic states
|
atherosclerosis, xanthomas, inflammation and necrosis, cholesterolosis, niemann-pick disease type c
|
|
How altered protein folding causes disease
|
Defective intracellular transport and secretion of critical proteins, and toxicity of aggregated abnormally folded proteins, ER stress
|
|
Hyaline change
|
Any alteration that imparts a homogeneous, glassy pink appearance in routine H&E staining. Intracellular: proximal tubule epithelial protein droplets, russell bodies, viral inclusions, and aggregated intermediate filaments. Extracellular: damaged arterioles
|
|
How altered protein folding causes disease
|
Defective intracellular transport and secretion of critical proteins, and toxicity of aggregated abnormally folded proteins, ER stress
|
|
Hyaline change
|
Any alteration that imparts a homogeneous, glassy pink appearance in routine H&E staining. Intracellular: proximal tubule epithelial protein droplets, russell bodies, viral inclusions, and aggregated intermediate filaments. Extracellular: damaged arterioles
|
|
Hemosiderin
|
Hemoglobin derived, yellow-brown, composed of aggregated ferritin. Granules formed when there is a local or systemic excess of iron
|
|
Melanin
|
Formed by enzymatic oxidation of tyrosine to dihydroxyphenylalanine in melanocytes
|
|
Hemosiderosis
|
Increased absorption of dietary iron, impaired use of iron, hemolytic anemias, transfusions
|
|
Dystrophic intracellular calcification
|
Occurs in mitochondria
|
|
Dystrophic extracellular calcification
|
Calcium concentrates in membrane bound vesicles full of phospholipids. Calcium ion binds, phosphatases release phosphate groups which bind to calcium, cycle is repeated, structural change takes place that generates a microcrystal of calcium and phosphate which can perforate the membrane
|
|
Principal causes of hypercalcemia
|
Increased secretion of parathyroid hormone, destruction of bone tissue, vitamin D related disorders, renal failure
|
|
Morphologic alterations due to cell aging
|
Irregular and abnormally lobed nuclei, pleomorphic and vacuolated mitochondria, decreased ER, distorted golgi apparatus
|